KCA

Dr. Katherine Alexander is a researcher, Assistant Professor, and Cancer Center Member at Cold Spring Harbor Laboratory, a biomedical research and education institution in New York. Dr. Alexander received a 2025 KCA Research Award for a project on "Nuclear Speckles as Prognostic and Predictive Indicators in ccRCC". We spoke with Dr. Alexander about her work and what it might mean…

Dr. Niki Zacharias Millward received a 2025 KCA Trailblazer Award for research on "Interrogating the Role of TRIP13 in Sarcomatoid Chromophobe Renal Cell Carcinoma". Dr. Millward previously received a KCA Research Award in 2023. Dr. Millward is an assistant professor in the Department of Urology – Research, Division of Surgery at MD Anderson Cancer Center in Houston, Texas. We spoke…

Dr. Miguel Zugman received a 2025 KCA Trailblazer Award in partnership with Kure It Cancer Research for research on "Stool microbiome assessment in a randomized phase I trial of nivolumab and ipilimumab with or without EXL01 in the first-line treatment of metastatic renal cell carcinoma (mRCC)". Dr. Zugman is a postdoctoral research fellow at City of Hope Comprehensive Cancer Center…

The Kidney Cancer Association (KCA) and the American Society for Radiation Oncology (ASTRO) partnered for a special joint session during the annual ASTRO meeting on September 30 in San Francisco, California. The session brought together an international, multidisciplinary panel of experts to discuss the emerging role of stereotactic ablative radiotherapy (SABR), a highly focused form of radiation therapy, to the…

The 2025 International Kidney Cancer Symposium: North America will feature three special awards honoring standout members of the kidney cancer community. The meeting will take place in Denver, Colorado from November 13-15. Register now. Dr. Michael Jewett Dr. Michael Jewett receives the Nicholas J. Vogelzang Humanitarian Award, named in honor of the KCA's late co-founder and Board member, for outstanding…

The Kidney Cancer Association (KCA) hosted the first-ever workshop to gather leading researchers from around the world, including two Nobel Prize winners, and discuss how to accelerate kidney cancer research at the preclinical stage to better understand this cancer and bring better treatments and diagnostic tools to patients.   The Renal Cell Carcinoma (RCC) Animal Model Workshop was hosted in partnership…

This is a guest post by Sarah Tuck, KCA’s Senior Manager of Patient Programs, who works on all the patient programs and education initiatives. I had the privilege of attending Stupid Cancer’s CancerCon in Washington, D.C. on August 23 on behalf of the Kidney Cancer Association (KCA). The conference brought together patients, survivors, caregivers, advocates, non-profit and health care professionals…

Cures don’t happen overnight. Research is slow. Step by step, each new discovery builds on all the discoveries that were made before. These might range from identifying a single, potentially cancer-causing genetic mutation to proving a new drug can target and kill cancer cells. Those really exciting research breakthroughs, the kinds that get written about in the news - like…

The newly launched Pediatric Renal Tumor Coalition (PRTC) brings together leading experts and national organizations focused on childhood cancer research and advocacy to accelerate progress for children diagnosed with kidney cancers. Founding members of the PRTC include the Kidney Cancer Association (KCA), Joey’s Wings Foundation, Wilms Cancer Foundation (WCF), Elevate Childhood Cancer Research and Advocacy (Elevate), and Kelly Trout, BSN,…

The end of May each year signals the beginning of summer and the ASCO Annual Meeting in Chicago. The Kidney Cancer Association’s Clinical Advisory Board (CAB) members conducted reviews of the kidney cancer discussions at this year's meeting for the entire kidney cancer clinical team. Read on to learn more! Results Reporting final efficacy and safety data in the intent-to-treat…